Previous 10 | Next 10 |
Third party net sales of $233.4 million Net loss of ($8.7) million; net loss margin of (3.7%); adjusted net income [ 1] of $17.6 million Diluted EPS of ($0.33); adjusted diluted EPS [ 1] of $0.67 Adjusted EBITDA [ ...
WESTMINSTER, Colo., July 20, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 10, 2022. Company management will h...
WESTMINSTER, Colo., July 12, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that Anthem Blue Cross Blue Shield (BCBS), a subsidiary/operating company of Elevance Health, has issued a positive medical policy...
ZimVie was spun out of Zimmer Biomet in March. Stock came under significant selling pressure From Day 1 due to technical factors. Current valuation is screening attractive at just 7.3x adjusted P/E. Investors are recommended to sharpen their pencils on ZimVie Inc. ( ZI...
ZimVie (NASDAQ:ZIMV) launched FDA-cleared dental solutions, T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the U.S. While, T3 PRO build on the company's T3 Tapered dental implant, Encode Emergence builds upon the Encode Impression System which provides clear intraor...
WESTMINSTER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the joint launch of the new, FDA-cleared T3 ® PRO Tapered Implant and Encode ® Emergence Healing Abutment in the...
ZimVie Inc. (ZIMV) Q1 2022 Earnings Conference Call May 5, 2022 16:30 ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President and Chief Executive Officer Rich Heppenstall - Chief Financial Officer Conference Call Participants Matt Miksic - Credit Suisse Presentation ...
The following slide deck was published by ZimVie Inc. in conjunction with their 2022 Q1 earnings call. For further details see: ZimVie Inc. 2022 Q1 - Results - Earnings Call Presentation
ZimVie press release (NASDAQ:ZIMV): Q1 Non-GAAP EPS of $0.50 beats by $0.12. Revenue of $235.6M (-4.9% Y/Y) beats by $10.73M. Cash balance of $104.3M at March 31, 2022. Adjusted EBITDA for Q1 2022 was $33.8M, or 14.4% of third party sales, a decrease of ($6.0) million compared to the fir...
Third party net sales of $234.7 million, inclusive of $120.6 million in dental net sales and $114.1 million in spine net sales Net loss of ($25.7) million; net loss as a percentage of net sales of (10.9%); adjusted net income [ 1] of $13.1 million Dil...
News, Short Squeeze, Breakout and More Instantly...
2024-06-25 20:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-25 07:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...